Axonics

Axonics Rule of 40

The Rule of 40 of Axonics (AXNX) as of Nov 19, 2026 is 26.75 %. In the previous year, Rule of 40 was 36.33 % — a change of -26.37% (lower).

Rule of 40

26.75 %

YoY

-26.37%

Last updated:

Rule of 40 of Axonics is 2023 26.75 % . Rule of 40 of Axonics was 2022 36.33 % . It decreases by -26.37% lower compared to the previous year.

The Axonics Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
-4,093.71 USD
Jan 1, 2019
1,271.53 USD
Jan 1, 2020
658.69 USD
Jan 1, 2021
21.79 USD
Jan 1, 2022
36.33 USD
Jan 1, 2023
26.75 USD
The Axonics Rule of 40 history
YEARRule of 40YoY
26.75 %-26.37%
36.33 %+66.73%
21.79 %-96.69%
658.69 %-48.20%
1,271.53 %-131.06%
-4,093.71 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axonics Stock analysis

What does Axonics do? Axonics Modulation Technologies Inc. is a medical device company that was founded in 2013 and is headquartered in Irvine, California. The company specializes in the development and marketing of innovative therapy devices for the treatment of bladder dysfunction and bowel diseases. Axonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axonics stock

Rule of 40 of Axonics is 26.75 % in 2023.

On Eulerpool you can find the complete historical development of Rule of 40 Axonics since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Axonics

All Key Metrics — Axonics